The maker of a drug for Lou Gehrig’s disease recently announced that it will pull the medicine from the market as it did not help patients with the condition. Amylyx Pharmaceuticals will halt sales and marketing of the drug in the U.
S. and Canada, and new patients will no longer be able to get a prescription. However, patients already taking the therapy can enroll in a program to receive it for free.
Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer: